Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Sphenopalatine Ganglion Block in Chronic Migraine
NCT02259075Phase 2Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Feb 2015
- Primary completion
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in chronic migraine (CM), sponsored by Norwegian University of Science and Technology. Started Feb 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic migraine (CM)
Beyond the preview
Go deeper on NCT02259075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02259075.